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Abstract
The gene encoding the receptor for macrophage colony-stimulating factor (CSF-1R) is expressed exclusively in cells of the
myeloid lineages as well as trophoblasts. A conserved element in the second intron, Fms-Intronic Regulatory Element (FIRE),
is essential for macrophage-specific transcription of the gene. However, the molecular details of how FIRE activity is
regulated and how it impacts the Csf1r promoter have not been characterised. Here we show that agents that down-
modulate Csf1r mRNA transcription regulated promoter activity altered the occupancy of key FIRE cis-acting elements
including RUNX1, AP1, and Sp1 binding sites. We demonstrate that FIRE acts as an anti-sense promoter in macrophages and
reversal of FIRE orientation within its native context greatly reduced enhancer activity in macrophages. Mutation of
transcription initiation sites within FIRE also reduced transcription. These results demonstrate that FIRE is an orientation-
specific transcribed enhancer element.
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Introduction
Macrophage colony-stimulating factor (CSF-1) controls the
proliferation, differentiation and survival of cells of the mononu-
clear phagocyte lineage [1,2]. CSF-1 mediates its actions by
binding to the CSF-1 receptor (CSF-1R), a type III receptor
protein tyrosine kinase. Expression of the Csf1r gene is switched on
early in myeloid lineage commitment, and expression levels
increase as immature myeloid cells differentiate into mature
macrophages [3]. The Csf1r transcript in macrophages is expressed
from a purine-rich promoter that lacks a TATA box and other
classical elements that specify the transcriptional start site, which
are characteristics shared with many other myeloid promoters [4–
6].
The proximal promoter of Csf1r is not sufficient to generate
maximal expression but requires the enhancer activity of a highly-
conserved ,330 bp sequence in the second intron downstream of
the macrophage promoter, which we named the Fms-Intronic
Regulatory Element (FIRE; [7,8]). This element is functionally
conserved between human and mouse [9] and the chicken Csf1r
locus also contains a conserved element in an equivalent location
within the first intron [10]. Deletion of FIRE from a GFP reporter
construct containing the promoter and downstream intron 2
sequence abolishes GFP expression in transgenic mice [8]. FIRE
contains multiple binding sites for myeloid transcription factors
commonly found in myeloid promoters including PU.1, RUNX1,
SP1/3, and AP-1 and lies within open chromatin in macrophages.
FIRE was shown to possess anti-sense promoter activity in
transient transfections of a macrophage cell line and subsequently,
two anti-sense transcription start sites were mapped within FIRE
[3]. Antisense promoter activity of FIRE was activated in B cells
by PAX5, and was associated with repression of Csf1r expression
[11].
Numerous genome-scale studies now indicate that promoter
activity associated with enhancers is widespread, producing what
have been called eRNA [12–14]. The function of these transcripts
appears to be highly variable. In the case of the beta-globin locus,
there is some evidence that transcription initiated from an
upstream enhancer has an essential function in the generation of
a chromatin loop that link enhancer and promoter [15] whereas
other eRNAs appear to be bystander products of enhancer activity
with as yet unknown functions [16]. In this paper, we present
evidence that FIRE is an anti-sense RNA Polymerase II promoter
in macrophages and is involved in fine-tuning Csf1r expression in
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response to stimuli. We provide evidence that the enhancer
activity of FIRE in its native context is orientation-dependent and
requires transcription initiation sites.
Results
Anti-sense FIRE Promoter Activity is Increased in the
Presence of Stimuli that Down-regulate Csf1r Expression
FIRE was shown previously to exhibit directional promoter
activity in transient and stable transfection assays of the
macrophage cell line RAW264.7 [7], suggesting a regulatory
function of anti-sense transcripts initiating within FIRE. We
therefore examined whether treatments that regulate Csf1r
transcription acted through FIRE and tested three such stimuli,
toll-like receptor agonists, CSF-1 and phorbol esters (PMA) [21] all
of which impact Csf1r expression. In transient transfections using a
construct carrying only the sense promoter, reporter gene
expression was unaffected by TLR agonists (LPS, bacterial
DNA) whereas FIRE anti-sense promoter activity was induced
3.2 fold with LPS stimulation and 1.7 fold, (p,0.05) by bacterial
DNA treatment (Figure 1A & B). Since RAW264.7 cells express
relatively low levels of receptor on the cell surface and do not
respond to CSF-1 treatment [22], we generated a stable cell line
over-expressing CSF-1R. This cell line was transfected with the
Csf1r promoter or the FIRE enhancer cloned in the antisense
orientation, and then treated with CSF-1, PMA, or both. CSF-1
actually induced the promoter as it has been reported to do in
fibroblasts expressing CSF-1R [23]. Both CSF-1 and PMA
induced FIRE promoter activity (Figure 1A & C). Together,
these data demonstrate that the anti-sense promoter activity of
FIRE is enhanced in the presence of stimuli that normally
downregulate Csf1r expression.
Csf1r Primary and Antisense Transcripts Increase in
Response to CSF-1 Deprivation While LPS & CSF-1 Cause
a Rapid Down-regulation
FIRE is located in open chromatin in mouse and human
macrophages [24] and tagged with H3K4Me3 suggesting an
active promoter [25]. It has been previously reported that Csf1r
mRNA expression is auto-regulated by its ligand. Growth factor
withdrawal up-regulates Csf1r expression while inflammatory
stimuli, such as LPS, down regulate expression. Both our own
data, and others [26,27] indicate that Csf1r down-modulation in
macrophages by LPS is associated with diminished production of
transcripts as detected in nuclear run-on transcription assays. To
confirm that this regulation takes place at the level of transcription
initiation, we measured primary transcripts using different primers
across the transcribed region. These measurements were com-
bined with chromatin immunoprecipitation (ChIP) experiments
testing for the recruitment of the initiating Serine 5 phosphory-
lated form of RNA-Polymerase II (RNA-Pol II) during a time
course of stimulation (Figure 2A & 2B). BMMs were starved of
CSF-1 for 24 hours to allow maximal upregulation of the surface
CSF1R, and Csf1r mRNA [28]. They were then stimulated with a
combination of LPS & CSF-1 to investigate the events that occur
as Csf1r is acutely down-regulated. Both primary RNA levels as
well as antisense RNA were measured during a time course of
stimulation. These experiments confirmed that the withdrawal of
CSF-1 from control cultures led to an up-regulation of Csf1r RNA
transcription which was associated with increased RNA Pol II over
the promoter. The addition of LPS & CSF-1 caused a rapid down-
regulation of RNA levels within two hours (Figure 2A) and an
even more rapid loss of initiating RNA Pol II (Figure 2B). Down-
regulation of RNA Pol II binding and RNA levels occurred across
the promoter as well as the FIRE enhancer, indicating that there
was not a primary block in elongation. Low levels of active
transcription were maintained for 16 – 24 hours whereas Serine 5
phosphorylated RNA-Pol II was replenished after 24 hours
(Figure 2A & 2B).
Primary RNA levels after 20 minutes of stimulation were still
high while RNA Pol II levels were already strongly reduced.
Moreover, increased amounts of RNA were detected over the
FIRE enhancer. We therefore considered the possibility that this
increase in RNA actually derives from antisense transcripts
initiated at FIRE. Detectable anti-sense transcripts found in B
cells were previously shown to initiate from two separate anti-sense
transcriptional start sites within FIRE [29]. One is in the vicinity of
the SP1/3/ETS/Egr-2/RUNX1 conserved element and the other
overlaps an AP-1 binding site. To confirm that anti-sense
transcripts are produced in primary macrophages, we performed
RT-PCR on mRNA from murine macrophages using three
distinct primer pairs, each of which produced bands of the
predicted size that were below the limit of detection in control
samples, but easily detected when cells were stimulated with CSF-
1 or LPS (Figure 2C). To confirm that the increased RNA at 20
minutes (Figure 2A) when RNA Pol II levels were strongly
suppressed (Figure 2B) is due to increased antisense transcription,
we measured the synthesis of FIRE antisense (as) RNA using
strand-specific primers (Figure 2D). Our results show a large
induction of asRNA after 20 minutes of LPS & CSF-1 treatment
indicating that asRNA is responsible for the increase in RNA.
Unidirectional antisense initiation from FIRE and the location of
the major TSS in primary mouse macrophages and in human
macrophages is confirmed by genome-scale 59 RACE (CAGE)
data generated by the FANTOM consortium [30–31]. More
recent CAGE data, sequenced at greater depth, confirms that
FIRE is a unidirectional ‘‘broad’’ promoter, which unlike a typical
TATA-less promoter, initiates transcription at multiple sites within
a broad window [31]. Although there are two major TSS peaks,
numerous minor peaks of initiation are detected within the 150 bp
window surrounding the major TSS (Forrest A. et al. Ms
submitted).The available data indicate that, in contrast to a major
subclass of enhancers [32], FIRE transcription initiation is not
bidirectional.
Combined CSF-1 and LPS Treatment Induces Transient
Occupation of Sp1 and AP1 binding sites within FIRE
Transcription factor occupancy on the Csf1r promoter and
FIRE was assessed by dimethyl sulfate (DMS) in vivo footprinting
over a time course of treatments with CSF-1 or LPS, as indicated
in Figure 3 A–C. These assays indicate protein contacts at the N7
position of guanines that protect these residues from being
methylated and also highlight hyper-reactivity to modification at
guanines juxtaposed to such a contact [33]. Untreated macro-
phages displayed the characteristic and complex transcription
factor binding pattern at the promoter and FIRE described
previously. We observed protein-DNA contacts over binding sites
for PU.1 (ETS), C/EBP, Sp and EGR family members as well as
RUNX1 consensus sequences [3] and this pattern remained
unchanged when the cells, after overnight growth factor
withdrawal, were treated with CSF-1 alone (Figure 3A). LPS
treatment of CSF-1 starved cells did not change transcription
factor occupancy at the promoter, but resulted in weak alterations
of DMS-reactivity at FIRE (Figure 3B). Here the LPS-induced
changes were restricted to an AP1 consensus sequence and to the
RUNX1/Sp1/ETS element as indicated by a reduction in DMS
reactivity (white squares). These two elements are juxtaposed to
the two start sites for anti-sense transcription [29]. Combined
Antisense Transcription and Regulation of CSF-1R
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treatment with CSF-1 and LPS produced more pronounced
changes (Figure 3C). DMS reactivity at the RUNX1/Sp1/ETS
element and at the AP-1 site was reduced within 30 minutes of
stimulation and returned to a pattern indistinguishable from
unstimulated cells after sixteen hours. As previously described, no
alterations of transcription factor occupancy were seen at the Csf1r
promoter [3]. These data suggest that the RUNX1/Sp1/ETS and
the AP-1 sites are maximally bound by protein in the presence of
CSF-1 and LPS.
Binding of AP-1 family proteins to the urokinase enhancer has
previously been shown to be induced by CSF-1 and PMA in bone
marrow-derived macrophages (BMM) [34]. Since we found that
the FIRE AP-1 site was occupied in our DMS footprint analysis in
cells stimulated with CSF-1 and LPS, we sought to determine if a
macrophage nuclear protein complex actually bound to the site.
There are two AP-1 consensus binding sites within FIRE
(Figure 4A). The consensus for the 59 AP-1 site (TGAATCA)
and the 39 AP-1 site (TGAGTTC) conform imperfectly to the
optimal AP1 consensus (TGA[G/C]TCA). Extract from both
stimulated and unstimulated RAW264.7 cells as well as BMMs
were compared to determine whether inducible macrophage
nuclear proteins bind to either of the putative AP-1 elements in
FIRE (Figure 4B). EMSA of the two candidate AP-1-like
elements within FIRE showed binding of an inducible protein
complex that could be competed for with an oligonucleotide
competitor containing the AP-1 consensus sequence from the
stromelysin promoter. Both sequences showed identical protein
complexes of the same relative mobility and abundance
(Figure 4B; data not shown). Binding of the AP-1-like protein
complex was inducible by LPS in RAW264.7 cells and by LPS,
CSF-1 or PMA in BMMs (Figure 4B). These data show that
binding activity that recognises the AP-1 element at FIRE is
induced by agonists that repress full-length Csf1r. Together, the
data demonstrate that maximal down-regulation of Csf1r tran-
scription requires CSF-1 and LPS signalling and that these signals
terminate at FIRE.
Sp1 Binding Sites and Transcription Start Sites are
Important for Promoter and Anti-sense Promoter Activity
within FIRE
Two major TSS within FIRE, located +2706 bp and +2760 bp
downstream of the translational ATG start site (Figure 4A), were
shown previously to be functionally active in B cells [11,20]. To
test the function of the TSS and putative control elements in
macrophages we generated a number of deletions and mutations
of FIRE in a luciferase reporter and tested them in RAW264.7
cells (Figure 4C). The minimal promoter activity of FIRE resides
on a small fragment (+2664 to +2723) containing two Sp1/3 sites
Figure 1. The FIRE region acts as an inducible promoter. (A) Schematic of FIRE constructs: the entire Csf1r regulatory region plasmid (pGL-
7.2 fms), for reference, the Csf1r promoter cloned into the pGL2B vector upstream of a luciferase reporter (pGL0.5 fms), FIRE in reverse orientation
was cloned into the pGL2B vector upstream of a luciferase reporter (pGLFIRE-). (B) RAW264.7 cells were transfected with pGL0.5 fms or pGLFIRE-.
Transfected cells were treated (+) with either LPS or bacterial DNA or left untreated (2) for 8 hours before assay of luciferase activity. (C) Naı¨ve
RAW264.7 cells (CSF-1R 2) or RAW264.7 cells stable transfected with a CSF-1R expression plasmid (CSF-1R +) were transfected with reporter
constructs as above and treated (+) with CSF-1 for 20 hours, PMA for 8 hours, or both CSF-1 & PMA or left untreated (2) before assay of luciferase
activity. Columns in B & C represent the mean RLU/mg protein and error bars the SEM of three independent assays which each showed the same
pattern.
doi:10.1371/journal.pone.0054935.g001
Antisense Transcription and Regulation of CSF-1R
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which have been shown to be functional [3]. Progressive removal
of other transcription factor binding sites from the 39 end of FIRE,
such as the AP-1 site overlapping the distal TSS, led to a
progressive reduction in activity. Removal of the Sp1 sites by
deletion of sequences upstream of +2725 severely reduced
promoter activity.
We also examined six- base pair deletions spanning each anti-
sense TSS (Figure 4D, left). The 59 anti-sense transcriptional
start site (AS TSS1; +2706) was dispensable for anti-sense
promoter activity whereas the 39 anti-sense start site (AS TSS2;
+2760), was absolutely required. The six base pair deletion
adjacent to DAS TSS2, D2753–2758 39 in reverse orientation,
were also required for anti-sense promoter activity but the six base
pairs on the other side (D2765–2770) were not (Figure 4D,
right). To confirm that the effect of deletion D2753–2758 on anti-
sense promoter activity was not due to the distance and position
relative to AS TSS1, we tested 3 other 6 bp deletions in the
sequence between AS TSS1 and AS TSS2. Deletion of D2747–
2752 or D2741–2746 had no effect on anti-sense promoter activity
while deletion of D2735–2740 was required for anti-sense
promoter activity. This indicates that the effect of deletion
D2753–2758 is driven by the base pair motif and not the distance
to AS TSS1 or 2 and that there are other necessary sites for anti-
sense promoter activity.
The Enhancer Activity of FIRE is Orientation Dependent
and Requires the Transcription Start Sites
FIRE enhancer activity is essential for basal Csf1r transcription
so dissection of the role of antisense transcription by mutational
analysis in mice is not straightforward. The traditional view of
enhancers is that their function is orientation-independent. To test
this, we produced a luciferase reporter construct in which the
Figure 2. Effect of CSF-1 and LPS on Csf1r primary and antisense transcripts. (A) Macrophages were differentiated from mouse bone
marrow under the influence of CSF-1. Cells were starved of CSF-1 for 24 hours, and then re-stimulated with a combination of CSF-1 and LPS. Primary
RNA levels containing intronic sequences were measured by Real-Time PCR assays using primers downstream of the promoter, FIRE or intron 3.
Normalisation was performed using rRNA-specific primers. Error bars represent the mean value of triplicate PCRs. (B) Cells and treatments were
identical to (A). ChIP assays measuring the recruitment of Serine 5 phosphorylated RNA Pol II using primers covering the indicated cis-regulatory
elements. Prom – 1.5 kb refers to a region upstream of the transcription start site which served as an internal negative control [29]. Values were
normalised against an internal negative control as described in materials and methods. Measurements are representative of at least two independent
experiments and error bars represent the mean value of three different measurements. (C) Primers were produced that contain sequence from the
positive strand of Csf1r upstream of the FIRE region within intron 2 (Asp1 or Asp2). These primers prime negative strand transcripts by reverse
transcriptase reaction (+). DNAse treated RNA was used for the reaction and as a control RNA was primed in the absence of reverse transcriptase (2).
cDNA products were detected by PCR with nested forward (NF1, NF2, or NF3) and reverse (NR) primers. (D) Cells and treatments were identical to (A).
Antisense RNA-expression was assayed by real-time quantitative PCR exactly as described in [20].
doi:10.1371/journal.pone.0054935.g002
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orientation of FIRE was reversed without introducing any other
sequence changes. Luciferase reporter constructs containing the
3.5 kb promoter alone (pGL2-3.5 fms), the intron-containing
native 7.2 Kb construct (pGL2-7.2 fms), or constructs in which
the 300 bp FIRE region was removed (pGL2-7.2 fms DFIRE) or
inverted (pGL2-7.2 fms FIRE-) were tested (Figure 5A, B & C).
As reported previously [7], the inclusion of the intron (pGL2-
7.2 fms) reduced the reporter gene expression in RAW264.7 cells
compared to the 3.5 kb promoter alone (pGL2-3.5 fms; data not
shown). As observed with EGFP-reporter genes in transgenic mice
[8], but not previously studied in transient transfections of
RAW264.7 cells, a construct in which FIRE was removed
(pGL2-7.2 fms DFIRE) was completely inactive. Replacement of
FIRE in the reverse orientation (pGL2-7.2 fms FIRE-) restored
less than ten percent the activity of the reporter plasmid
(Figure 5B). Additionally, the reporter constructs were treated
with LPS to determine the effect on activity. The pGL2-3.5 fms
plasmid was LPS unresponsive, whereas the activity of pGL2-
7.2 fms was repressed by LPS. The pGL2-7.2 fms FIRE- actually
had increased activity in the presence of LPS demonstrating that
reversing enhancer orientation prevented inhibition by LPS
(Figure 5C). To confirm the role of antisense transcription in
the enhancer activity of FIRE, we inserted the same 6 bp deletions
tested in Figure 4D into the 7.2 kb intron-containing reporter
construct (pGL2-7.2 fms). Mutation of either of the TSS caused a
partial reduction of reporter gene expression. The six base pair
deletion adjacent to DAS TSS2, D2765–2770, were also required
for enhancer activity but the six base pairs on the other side
(D2753–2758) were not (Figure 5D).
Discussion
Antisense Promoter Activity Correlates with the
Regulation of Csf1r Expression
FIRE is a complex enhancer element that is essential for
macrophage-specific expression of the Csf1r gene, but at the same
time also required for acute regulation by a range of stimuli. The
dissection of these different properties is a difficult task. The Ets
family transcription factors, PU.1 and Ets2 transactivate the Csf1r
promoter and the purine-rich target elements bound by these
factors are necessary and sufficient for transcription initiation in
macrophages. LPS, CSF-1 and PMA regulate both PU.1 and Ets2
at their level of expression and phosphorylation [5,35,36].
However, this did not impact on their activity on the Csf1r
promoter as its basal activity was marginally activated by agents
that repress mRNA expression (Figure 1). Instead, our data show
that altered promoter activity is a consequence of altered
transcription factor binding to FIRE. Stimulation with LPS and
CSF-1 altered occupancy of functional binding sites for the
transcription factors AP-1 and Sp1 (Figure 3), correlating with
increased abundance of these factors in the nucleus. This indicates
that FIRE enhancer activity and FIRE promoter activity are
driven by alternative sets of transcription factor complexes.
Activation of antisense transcription with LPS, PMA or CSF-1
correlates with a decrease in expression. This finding recapitulates
the observation in B cells that PAX5 acts to repress Csf1r
transcription by blocking the main promoter but also inducing the
antisense promoter [11]. The enhancer activity of FIRE is
associated with the deposition of active histone marks likely to
require PU.1, C/EBP and RUNX1 (AML1), all of which bind to
FIRE in both mouse and human. The latter protein binds to two
sites within mouse FIRE, and expression of Runx1 mRNA and
nuclear binding activity is repressed by CSF-1 [28] which would
be consistent with the up-regulation of Csf1r mRNA in the absence
of CSF-1(Figure 4A).
We previously provided evidence that the Csf1r proximal
promoter was active in non-macrophage tumour cells, and was
growth factor-responsive [23]. We suggested that FIRE acted in
part to prevent read through of the intron, producing a block to
transcription elongation, and that this might also explain the
repression by LPS, PMA and CSF-1 [21]. However, this
mechanism of regulation is incompatible with the data in
Figure 2. Instead, the data demonstrates a complex interplay
between the main promoter and FIRE in response to inflamma-
tory stimuli which leads to direct and rapid repression of
transcription initiation. That conclusion is consistent with earlier
studies of LPS action using nuclear run-on transcription [37].
CSF-1 starvation of BMM produced an increase in primary Csf1r
transcripts from the promoter and also from FIRE, paralleled by
increased association of active RNA Pol II. Addition of LPS and
CSF-1 caused an immediate increase of the antisense transcripts
followed by a rapid decrease of active RNA Pol II occupancy and
a slow decrease in primary transcripts across the coding region.
This precise temporal correlation suggests that the interplay
between sense and antisense transcription is of relevance for the
regulation of Csf1r mRNA levels. However, while the effects of
transcriptional interference have been described in yeast [38] there
have been few studies of the consequences of bidirectional
transcription initiation in mammals and more elaborate experi-
mentation is necessary to dissect the precise molecular details at
Csf1r.
The Activity of FIRE in situ is Orientation Dependent
Enhancers are supposed to act in a position and orientation-
independent manner. However, reversing an enhancer in its native
context has rarely formally tested this definition. Our experiments
clearly demonstrate that in its native context the enhancer activity
of FIRE is orientation dependent. Experiments with stably
transfected cells and transgenic mice have shown that the Csf1r
promoter alone is insufficient to mediate maximal expression of a
reporter gene in a chromatin environment. Moreover, in the
absence of FIRE, the presence of intronic sequences repressed this
basal activity even further [7]. FIRE may therefore act as an anti-
repressive element, relieving transcription arrest by so far
uncharacterised repressive elements within the intron. This
essential ‘‘anti-repressive’’ activity is ablated by reversing the
orientation of FIRE (Figure 5B). By inference, the antisense
transcript may contribute to the ability of the FIRE sequence to
overcome repression by the remainder of the intron. A similar
mechanism has been documented in the LPS-induced up-
Figure 3. In vivo DMS footprinting of the Csf1r promoter and FIRE in stimulated BMM. Macrophages were differentiated from mouse bone
marrow under the influence of CSF-1 (+) and subjected to DMS footprinting after either starving cells of CSF-1 (2) or restimulation with CSF-1 (A), LPS
(B), or CSF-1 & LPS (C) for the indicated time points. G: Maxam-Gilbert reaction followed by LM-PCR with purified genomic DNA. ES: In vivo
footprinting performed with ES cells. Putative transcription factor binding sites in chromatin showing alterations in methylation compared to a
Maxam-Gilbert G-reaction of naked genomic DNA are shown as vertical bars on the right hand side of the gel images. Nucleotide positions relative to
the ATG start are designated by numbers on the left. Macrophage specific footprints are indicated as circles (black: enhancement, white: inhibition)
while LPS responsive footprints are indicated as squares (black: enhancement, white: inhibition). L-shaped arrows are the position of antisense RNA
start sites at FIRE.
doi:10.1371/journal.pone.0054935.g003
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regulation of the lysozyme locus [39]. Here transcription from an
inducible antisense promoter upstream of the normal transcription
start site suppresses the activity of a silencer element by
reorganising chromatin architecture and altering transcription
factor binding. Cook et al. [40] first suggested that transcription
arising from enhancers may act to focus enhancers and target
promoters into active transcription factories, facilitating cis-
element interaction and concentrating transcriptional regulators
around the start site. The data herein could support such a
mechanism of action for FIRE. A cis-acting mechanism is also
favoured by a lack of trans-acting effects of the intron. Co-
transfection of a 10-fold excess of the 7.2 kb Csf1r promoter
fragment containing FIRE, had no effect on expression of the
7.2 kb Csf1r-luciferase reporter gene in RAW264.7 cells (data not
shown). The fact that many enhancers generate transcripts makes
it likely that the activity of such elements to stimulate transcription
in their native chromatin environment could also be orientation
dependent.
Materials and Methods
Ethics Statement
Animals were allowed free access to food and water and were
maintained under temperature, humidity and light-controlled
conditions. In accordance with the United Kingdom Animal
(Scientific Procedures) Act of 1986, this study did not require a
Home Office project license because no regulated procedures were
carried out. Mice were humanely killed at a designated
establishment by exposure to carbon dioxide gas and/or
dislocation of the neck, which are appropriate methods under
Schedule 1 of the Act.
Cell Culture
Bone marrow cells were isolated from the femurs and/or tibias
of adult C57Bl/6 mice exactly as in Schroder, et al. [17] and
cultured in RPMI or IMDM media containing penicillin-
streptomycin, GlutaMAX-I supplement, and 10% fetal bovine
serum. Cells were differentiated to macrophages by a 6–7 day
treatment with 1000 units of human CSF-1 (Chiron Corp.,
Emeryville, CA) or with 10% L929 conditioned medium as a
source of mouse CSF-1. RAW264.7 cells (obtained from the
American Type Culture Collection) were cultured in RPMI
medium with the above supplements.
Plasmids
The pGL0.5 fms, pGLFIRE-, pGL-7.2 fms, pGL-3.5 fms,
pGL-7.2 fms DFIRE plasmids have been described previously
[7]. All reporter constructs in Figure 4C carrying deletions or
point mutations within FIRE have been described previously [11].
The pGL-7.2 fms FIRE- plasmid was produced by deletion of the
FIRE region using splice overlap PCR on an Xho1 fragment at
the end of intron 2 excised from the pGL-7.2 fms plasmid. Primers
for splice overlap introduced an Asc1 site into the sequence and
FIRE was cloned in the inverted orientation before reinsertion of
the Xho1 fragment into the pGL-7.2 fms plasmid. In Figure 4D,
the generation of pGLFIRE- six base pair (bp) deletion mutants
were generated across the 337 bp FIRE sequence using splice
overlap PCR using a modified protocol based on published reports
[18,19]. Universal external PCR primers were designed with
flanking AscI sites to facilitate cloning. TAGC AscFire
CB F: 59TACGGGCGCGCCCCAGGAGGCCAGGGAAGC39
TACG FIRE CB ASC R: 59TACGGGCGCGCCGTACC-
CAGTCTGCCCTCG39 Internal primers containing six bp
deletions were systematically designed across FIRE with eighteen
bp flanking each side of the deletion. PCR reactions contained a
final concentration: 1 mMMgSO4, 0.3 mM each dNTP, 0.4 mM
each primer and 0.5U Platinum Pfx Polymerase (Invitrogen,
Carlsbad, IN). Cycling parameters were 94uC for 2 min; 94uC for
15 sec, 60uC for 30 sec, 68uC for 30 sec for 30 cycles followed by
68uC for 1 minute once. PCR products were gel purified using
Qiagen Extraction Gel Kit (QIAGEN, Valencia, CA) as per
manufacturer’s instructions. Two microliters of each PCR reaction
for each mutation was used for second round PCR. Second round
PCRs were performed and cycled as above but no primers were
added and fifteen cycles were performed. After fifteen cycles, the
external primers (TAGC AscFire F2 and Asc Univ Fire Rev) and
0.2U Taq were added and cycled for 30 rounds of PCR. PCR
products were purified using Qiagen Gel Extraction Kit, as above
and then digested with AscI (NEB), and heat inactivated for
20 min at 65uC. These products were directly ligated into PGL2B
that had an AscI site inserted into the SmaI site to facilitate cloning
purposes. Correct clones were confirmed by AscI digest and
sequence analysis. In Figure 5D, the generation of pGL-7.2 fms
six base pair (bp) deletion mutants were generated using splice
overlap PCR using a modified protocol based on published reports
[18,19]. Universal external PCR primers were designed within
FIRE as well as internal primers containing the same four 6 bp
deletions from Figure 4D with eighteen bp flanking each side of
the deletion. PCR conditions were the same as above. These
products were directly ligated into pGL-7.2 fms using native XhoI
sites. Correct clones were confirmed by restriction enzyme digest
and sequence analysis.
Transfection
Stable transfections were performed by electroporation of
56106 cells in 250 ml RPMI media containing 20 mM HEPES
Figure 4. Sp1 binding sites and transcription start sites are important for promoter and anti-sense promoter activity within FIRE. (A)
Schematic of two separate anti-sense transcriptional start sites within FIRE. One is in the vicinity of the Egr-2/RUNX1/Sp1/3 conserved element and
the other overlaps the AP-1 binding site. Indicated transcription factor binding sites are based on the DMS footprinting data depicted in Figure 3. (B)
EMSA analysis using an oligonucleotide containing the FIRE 59 AP-1 like binding site and nuclear extract from RAW264.7 cells or BMMs with or
without treatment with LPS (L), PMA (P), or CSF-1 (C). Bands were identified as AP-1 like (AP-1L) by specific competition with an oligonucleotide
containing a consensus AP-1 binding site (AP-1) and not by a random sequence oligonucleotide (R). (C) Luciferase constructs carrying deletions of
FIRE or a point mutation as indicated were transfected into RAW264.7 cells and luciferase activity was measured after 24 h. The experiments show the
mean value of two independent experiments whereby each construct was transfected three times. Statistically significant differences versus Msc FIRE
R are indicated (t-test; ***p,0.001, **p,0.01, and *p,0.05). (D) Left: Schematic of FIRE reverse constructs. FIRE in reverse orientation was cloned into
the pGL2B (pGL2) vector upstream of a luciferase reporter (pGLFIRE-). The locations of the two antisense transcriptional start sites (AS TSS1 and AS
TSS2 within context of FIRE) and the relative positions of the 6 bp deletions used in the experiment are shown. Right: RAW264.7 cells were
transfected with each construct shown on the left or with empty pGL2B vector (pGL). Twenty-four hours post transfection, cells were treated with
100 ng/ml LPS for 6.5 h and luciferase activity was assessed. Columns represent the mean RLU/mg protein, black bars indicate mock treated samples
and white bars indicate LPS treated samples. Results were almost identical in two independent experiments whereby each construct was individually
electroporated three times; a representative graph is shown, with error bars representing the SEM of triplicates from a single experiment. Statistically
significant differences versus mock-treated pGLFIRE- are indicated (t-test; *p,0.05).
doi:10.1371/journal.pone.0054935.g004
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Figure 5. The enhancer activity of FIRE is orientation dependent and requires the transcription start sites. (A) Schematic of FIRE
constructs: the entire Csf1r regulatory region plasmid (pGL-7.2 fms), pGL-7.2 fms with FIRE subcloned into the reverse orientation (pGL-7.2 fms FIRE-),
pGL-7.2 fms with FIRE deleted (pGL-7.2 fms DFIRE), and pGL-7.2 fms with intron 2 deleted leaving 3.5 Kb of the Csf1r promoter (pGL2-3.5 fms). (B)
RAW264.7 cells were transfected with pGL-7.2 fms, pGL-7.2 fms FIRE-, or pGL-7.2 fms DFIRE constructs and luciferase activity was assessed. Data is
shown as a percentage of pGL2-7.2 fms (100%) and error bars represent the SEM. Statistically significant differences versus pGL-7.2 fms are indicated
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and 10 mg reporter with 1 mg pPNT neomycin resistance plasmid
at 280 volts and 1000 mFarad capacitance on a Bio Rad Gene
Pulser (Bio Rad), followed by selection with 250 mg/ml Geneticin.
For stable transfection, antibiotic resistant cells with or without 48
hours of LPS treatment were analysed on a Facstar flow cytometer
(Becton Dickinson). The extended treatment with LPS was
required to see repression of the stable EGFP protein. Transient
transfections were performed as above with 10 mg of reporter
plasmid without the additional antibiotic resistance plasmid. In
Figure 4C, RAW264.7 cells were transfected using a 1:3 ratio of
lipofectamine and plasmid (0.6 mg of FIRE constructs reporter
vectors, 0.25 ng of Renilla and 0.2 mg of pBluescript) in 250 mL
Opti-mem (Gibco; Invitrogen). Cells were transfected for 24 hours.
Treatment
Figure 1: (B) 24 hours post-transfection, cells were stimulated
with either 20 ng/ml LPS or DNA for 8 hours before lysis. (C) 24
hours post-transfection, cells were stimulated with either 1000 U/
ml of CSF-1 for 20 hours, PMA (1027 M) for 8 hours, or a
combination of CSF-1 and PMA before lysis. Figure 2 (A/B/D):
Cells were cultured in M-CSF free medium for 24 hours and
subsequently treated with 20 ng/ml LPS (Sigma) and 50 ng/ml
murine recombinant M-CSF (Peprotech) for 20 min to 24 hours.
(C): Cells were stimulated with either 20 ng/ml LPS or 1000 U/
ml of CSF-1 for 8 hours. Figure 4 (D): 24 hours post-transfection,
cells were stimulated with 100 ng/ml LPS for 6.5 hours Figure 5
(C): 24 hours post-transfection, cells were stimulated with 100 ng/
ml LPS for 8 hours.
Luciferase Assay
Luciferase activity was assayed according to the manufacturer’s
protocol (Roche Biochemical). pGL2 basic and pGL2 luciferase
reporter vectors were used as controls. The concentration of
protein was determined by BCA protein assay (Pierce) and the
level of luciferase activity was given as relative light units (RLU),
calculated as light units/ mg of protein assayed. Samples in
Figure 4C were assayed for luciferase activity using the Promega
Dual Luciferase assay system.
RNA Isolation and Quantification
Total RNA was prepared using RNeasy isolation kits (QIA-
GEN) according to the manufacturer’s instructions or by TRIzolH
(Invitrogen). RNA was treated with DNaseI and reverse
transcribed into cDNA using reverse transcriptase. For
Figure 2A, cDNA were quantified using real-time quantitative
polymerase chain reaction (qPCR) with SYBR Green, ABI 7500
real-time PCR system (Applied Biosystem), and the following
oligonucleotides: c-fms prom (For: CTGCTGCTGGCCA-
CAGTTT and Rev: CAGCGATGCCCTCTTTGC), Fire 59
(For: GGAAACCCTGAAGTCCTCTAAGG and Rev:
TGACCCCGCAAGTCAACC), FIRE 39 (For: CAGACTGGG-
TACCTCTCTCCTTCAT and Rev: GCCAG-
GAAACCGTTGTGTCAT) and intron 2 (For: TGACCAAG-
CACCTAGAGCAA and Rev: GATCAAAGGCCTGAGCAT-
CT). For Figure 2C, negative control samples (no first strand
synthesis) were prepared by performing reverse transcription
reactions in the absence of reverse transcriptase. Detection of
antisense RNA was determined by priming of mRNA with the
following oligonucleotides: ASp1; GGAGAAGTGTCTG-
GAACC, ASp2; CTGGCTGGTTGGAGGCTTGG and PCR
amplification with NF1; GTACGGCCTGAGAACAG-
CAGGTGG, NF2; GAGTTTGAATCAGAGTGA, NF3; CAG-
GACAGTGGCACAGCACAGACA NR; TGTCCTTCTCA-
CACACTGAGGGAC.
Antisense RNA Assay
Antisense RNA-expression was assayed exactly as described in
[20]. Briefly, cDNA was synthesised from 2 mg of DNaseI-treated
total RNA by using 400 U of M-MLV reverse transcriptase and
biotinylated primers specific for antisense-Csf1r transcript
([Btn]GGTCAGCAAACAGGACAGTGGCACAGCACAGAC-
AG) (2 pmol) and rDNA ([Btn]GCACCGCGACAGACC-
CAAGCCAGTA) (0.2 pmol) in one reaction. Synthesised cDNA
was immobilised on Dynabeads (Dynal, M-280). RNA and trace
amounts of genomic DNA were removed by alkaline denatur-
ation and serial washing. cDNA was eluted by heating the bead
suspension in 0.1TE for 15 min at 95uC and was followed by
qPCR using antisense-Csf1r (FIRE4 for:
TGTGCCCAGTCTGCTCTAA and FIRE4 rev:
CTCCTGGCCATTGTCCTTCTC) and rDNA (rDNA for:
CTGTCCTTTCCCTATTAACACT and rDNA rev: GAA-
TAGGCTGGACAAGCAAAACA) primers. Primers amplifica-
tion efficiency was calculated using genomic DNA as a
standard. Antisense-Csf1r expression was normalised against
rDNA signals.
Chromatin Immunoprecipitation Experiments
Sub-confluent bone marrow derived macrophages were har-
vested and washed in cold PBS. Chromatin was cross-linked with
1% formaldehyde (Thermo Fisher Scientific, IL USA) for 1 hour
at 4uC. The cells were lysed in 10 mM HEPES (pH 8), 10 mM
EDTA, 0.5 mM EGTA, 0.25% Triton X100 and protease
inhibitor cocktail (PIC). The nuclei were collected by centrifuga-
tion and lysed in 10 mM HEPES (pH 8), 200 mM NaCl, 1 mM
EDTA, 0.5 mM EGTA, 0.01% Triton X100 and PIC. Chromatin
was transferred to IP buffer containing 25 mM Tris-HCl (pH 8),
2 mM EDTA, 150 mM NaCl, 1% Triton X100, 0.25% SDS, PIC
and sheared using a Bioruptor sonicating water bath (Diagenode)
to an average length of 200–500 bp. The chromatin solution was
diluted in 25 mM Tris-HCl (pH 8), 2 mM EDTA, 150 mM NaCl,
1% Triton X100, 7.5% glycerol and antibody precipitations were
performed. Chromatin from 106 cells and 10 ml of Dynabeads
protein G (Invitrogen) coupled with 1 mg of RNAP II S5 antibody
(ab5131; Abcam, Cambridge, United Kingdom) were incubated
for 2 hours at 4uC with rotation. The immune complexes were
collected using a magnet separator and washed with low salt wash
buffer 1 (20 mM Tris-HCl (pH 8), 2 mM EDTA, 1% Triton
X100, 0.1% SDS, 150 mM NaCl), high salt wash buffer 2 (20 mM
Tris-HCl (pH 8), 2 mM EDTA, 1% Triton X100, 0.1% SDS,
500 mM NaCl), LiCl buffer (10 mM Tris-HCl (pH 8), 1 mM
(t-test; ***p,0.001). (C) RAW264.7 cells were transfected with pGL2-3.5 fms, pGL-7.2 fms, or pGL-7.2 fms FIRE- constructs. Following treatment with
LPS, luciferase activity was assessed. Data for each construct are shown normalised to the same construct untreated and error bars represent the SEM.
Statistically significant differences between the LPS treated construct versus the same construct untreated are indicated (t-test; **p,0.01). (D)
RAW264.7 cells were transfected with linearized pGL-7.2 fms or a linearized pGL-7.2 fms construct containing one of the four 6 bp deletions in FIRE
shown in Figure 4D. Forty-eight hours post transfection, luciferase activity was assessed. The data represents six separate experiments performed in
triplicate and error bars represent the SEM. Data are shown as a percentage of pGL2-7.2 fms (100%). Statistically significant differences versus pGL-
7.2 fms are indicated (t-test; *** p,0.001, ** p,0.01, and * p,0.05).
doi:10.1371/journal.pone.0054935.g005
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EDTA, 0.25 M LiCl, 0.5% NP40, 0.5% Na deoxycholate) and
TE/NaCl buffer (10 mM Tris-HCl (pH 8), 1 mM EDTA, 50 mM
NaCl). Precipitated DNA was eluted in 1% SDS and 100 mM
NaHCO3 and followed by crosslink reversal by heating at 65uC
overnight. Chromatin DNA was purified using Ampure PCR
purification kit (Agencourt AMPure, APN 000130) and quantified
using real-time qPCR with SYBR Green. Primers used in this
assay were Prom -1.5 kb (For: CACGCCGGCTGAGTGTCT
and Rev: TCCACGTAGATGGTGTCAGCAT), c-fms prom
(For: CTGCTGCTGGCCACAGTTT and Rev: CAGC-
GATGCCCTCTTTGC), Fire 59 (For: GGAAACCCT-
GAAGTCCTCTAAGG and Rev: TGACCCCGCAAGT-
CAACC), FIRE 39 (For: CAGACTGGGTACCTCTCTCCT-
TCAT and Rev: GCCAGGAAACCGTTGTGTCAT) and
intron 2 (For: TGACCAAGCACCTAGAGCAA and Rev:
GATCAAAGGCCTGAGCATCT).
In vivo DMS Footprinting
Bone marrow macrophages (BMM) were deprived of CSF-1 for
24 hours, and then restimulated with CSF-1 (10% L929 cell
conditioned medium) or 20 ng/ml LPS or the combination as
indicated. At the end of each incubation time, cells were washed
with PBS and treated with 0.2% DMS/PBS for 5 minutes at room
temperature. After three washes with ice-cold PBS, genomic DNA
was extracted from cells and subjected to piperidine cleavage and
Ligation-mediated PCR (LM-PCR) amplification. LM-PCR was
performed as described previously [3].
EMSA
Isolation of nuclei and extraction of protein from BMMs and
RAW264.7 cells was performed according to established protocols
and the concentration of protein in nuclear extracts was
determined by BCA protein assay. The double stranded oligonu-
cleotide probes used contained the following sequences; CSF-1R
Sp1: CAGGCTGGGCGGAAACCA CSF-1R Ap-1:
AGGCTGTGAATCAGTTCTCA. Binding reactions contained
20 mM HEPES buffer pH 7.4, 40 mM NaCl, 15% glycerol, 1 mg
of protein from nuclear extract, 25 ng poly (dI-dC) and
approximately 0.01 pmole of 32P labelled probe for 20 minutes
at room temperature. Antibody supershifts were performed by pre-
incubating binding reactions with a-Sp1 antibody (Santa Cruz
Biotechnology) for 15 minutes at 4uC before addition of probe and
protein binding. Competitions were performed by addition of
unlabelled oligonucleotide corresponding to the stromelysin AP-1
consensus element at a ratio of 20 to 1 immediately before
addition of labelled probe. Protein binding was resolved on 5%
mini-polyacrylamide gels (Bio Rad) in 0.5 XTBE (45 mM Tris
base, 45 mM boric acid, and 1 mM EDTA) for 1 hour at 100
volts.
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